On December 7, 2025, Shenzhen hosted a grand academic event in the field of tumor treatment—the 12th Annual Academic Conference and a series of cutting-edge exchange meetings of the World Federation of Chinese Medicine Societies’ Professional Committee on External Treatment of Tumors. The event brought together numerous experts, scholars, and industry representatives from both traditional Chinese and Western medicine in the field of tumor prevention and treatment, both domestically and internationally, to jointly explore the latest advancements in external treatment of tumors and their integration and innovation in the digital and intelligent era. Taiai Peptide Group was invited to participate in this provincial conference.
The conference focused on the theme of “Digital and Intelligent Integration, Inheritance and Innovation,” and featured several high-level academic reports and thematic discussions. Participating experts engaged in in-depth exchanges on the unique advantages and latest research findings of TCM external treatment techniques in adjuvant cancer therapy and rehabilitation management. They also explored how modern technologies such as artificial intelligence and big data can empower the standardization, precision, and personalization of TCM cancer diagnosis and treatment, outlining a future blueprint for “Digital and Intelligent TCM Oncology.”
At the conference, Taiai Peptide Group showcased a range of peptide products. The successful hosting of this conference injected technological momentum into the modernization of traditional Chinese medicine’s external treatment methods for tumors. As a vice-chairman unit of the Shenzhen Association of Traditional Chinese Medicine Practitioners, the group stated that it will continue to increase its R&D investment, focusing on bioactive peptides, to promote the deep integration of peptide science and traditional medicine, and better bring healthy beverages to the Chinese people.
Post time: Dec-10-2025